€100.38
Your prediction
Description Agilent
Agilent Technologies Inc. (Symbol A) is a leading global biotechnology and electronic measurement company. It was originally established in 1999 as a spin-off of Hewlett-Packard and is headquartered in Santa Clara, California, United States. Agilent provides a wide range of solutions to customers in life sciences and diagnostics, chemical analysis, electronic measurement, and communications industries.
The company operates in three business segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Its Life Sciences and Applied Markets segment deals with research products and services, which include gas chromatography, liquid chromatography, and mass spectrometry systems that are used to analyze organic chemicals and biological molecules. Meanwhile, its Diagnostics and Genomics segment offers laboratory instruments, software, and consumables that are used for diagnosing and identifying diseases, testing for genetic abnormalities, and conducting genomics research.
Agilent's third segment, Agilent CrossLab, offers laboratory supplies and services and supports workflows across various industries. Its products and services include laboratory information management systems, sample preparation products, instrument services, and software solutions.
Overall, Agilent is a well-diversified company that serves a range of end markets with its innovative product portfolio. It generates a significant portion of its revenue from the United States, but also operates in several other countries around the world.

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Competitors of Agilent
Agilent is a company that operates in the industry of Life science, Diagnostics, and Applied markets. The company is involved in developing and manufacturing scientific instruments, software, and consumables for laboratories. Some of Agilent's key competitors in this industry include:
1. Thermo Fisher Scientific (Symbol TMO) - Thermo Fisher Scientific is a company that develops, manufactures, and sells scientific instruments, reagents, and consumables. The company operates in the life sciences, clinical research, industrial, and food safety markets. Thermo Fisher Scientific is considered one of the largest players in the industry and has a wide range of product offerings.
2. Danaher Corporation (Symbol DHR) - Danaher Corporation is a conglomerate that has a wide range of businesses in different markets. The company operates in the life sciences, diagnostics, industrial, and environmental markets. Danaher Corporation has a diverse portfolio of products and services, which makes it a major competitor for Agilent.
3. Waters Corporation (Symbol WAT) - Waters Corporation is a company that provides analytical instruments, software, and services for life sciences and applied markets. The company specializes in technologies such as mass spectrometry, chromatography, and thermal analysis. Waters Corporation is a leading player in the industry and has a strong presence in the global market.
4. Bruker Corporation (Symbol BRKR) - Bruker Corporation is a company that develops and manufactures scientific instruments and analytical solutions for life sciences, materials research, and applied markets. The company's product portfolio includes mass spectrometers, spectroscopy solutions, and microscopy systems. Bruker Corporation operates globally and competes with Agilent in several markets.
In summary, Agilent competes with some of the largest companies in the life sciences and diagnostics industry, including Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, and Bruker Corporation. These companies have a diverse product portfolio and are known for their strong presence in the global market.
Suppliers of Agilent
Agilent is a company that provides analytical instruments, software, services, and consumables for the life sciences, diagnostics, and applied chemical markets. As such, the most important suppliers for Agilent are likely those that provide the materials and components needed to manufacture its products.
Some of Agilent's key suppliers include:
1) Applied Materials, Inc: Provides materials engineering solutions, including semiconductor equipment and processes.
2) Lam Research Corporation: Provides materials technology solutions for the semiconductor industry.
3) Heraeus: Provides precious metals and technical solutions for the life sciences, electronics, and industrial sectors.
4) Merck KGaA: Provides products and services for the life sciences and healthcare industries, including laboratory chemicals, equipment, and consumables
5) Sigma-Aldrich Corporation: Provides chemicals, reagents, and other laboratory consumables for the life sciences, biotechnology, and industrial sectors.
Financial data and news for Agilent
sharewise wants to provide you with the best news and tools for Agilent, so we directly link to the best financial data sources.
Financials
News

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph.
The updated release reads:
AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL

Agilent to Showcase New Products and Innovations at HPLC 2025
Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and up 5.3% core(1) compared with the

Agilent Names August Specht as Chief Technology Officer
Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company’s Chief Technology Officer. Specht, previously vice president of Global R&D for the

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series
Agilent Technologies Inc. (NYSE: A) today announced the launch of its latest innovation in liquid chromatography (LC)-mass detection: the Agilent InfinityLab Pro iQ Series. This groundbreaking

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance
Agilent Technologies Inc. (NYSE: A) today announced the latest enhancements to the Agilent 8850 Gas Chromatograph (GC), including compatibility with single and triple quadrupole mass spectrometry

Agilent Announces Cash Dividend of 24.8 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on July 23, 2025, to all shareholders of

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors
Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series
Agilent Technologies Inc. (NYSE: A) today announced that the Infinity III LC Series — the company’s latest liquid chromatography (LC) instruments — are the first Agilent instruments to receive the

Agilent to Participate in Jefferies Global Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at the Jefferies Global Healthcare Conference at

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research
Agilent Technologies Inc. (NYSE: A) today announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well system designed to expand real-time metabolic analysis into optimized

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR certification for the use as a Companion Diagnostic (CDx) to aid in the

Agilent to Announce Second-Quarter Fiscal Year 2025 Financial Results on May 28
Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2025 after the stock market closes on Wednesday, May 28. In addition, the company will host

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL®, a recently approved CAR T therapy. Agilent's advanced cell

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski, an internationally recognized

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of

Agilent to Participate in TD Cowen Health Care Conference
Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference at

Agilent Reports First-Quarter Fiscal Year 2025 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% core(1) compared to the first

Agilent Announces Cash Dividend of 24.8 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on April 23, 2025, to all shareholders of

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. In addition, the company will host

Agilent Automated Workflows at SLAS2025: Connecting with Confidence
Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Exhibition being held January 25-29

Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists
Agilent Technologies Inc. (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of Aarhus University, Professor Walter Gössler of